Virtu Financial’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-143,537
| Closed | -$27K | – | 2060 |
|
|
2024
Q1 | $27K | Buy |
143,537
+131,248
| +1,068% | +$24.7K | ﹤0.01% | 1129 |
|
|
2023
Q4 | $14K | Buy |
+12,289
| New | +$14K | ﹤0.01% | 1377 |
|
|
2023
Q3 | – | Sell |
-471
| Closed | -$3K | – | 2084 |
|
|
2023
Q2 | $3K | Sell |
471
-126
| -21% | -$803 | ﹤0.01% | 1423 |
|
|
2023
Q1 | $17K | Buy |
597
+358
| +150% | +$10.2K | ﹤0.01% | 1283 |
|
|
2022
Q4 | $16K | Buy |
+239
| New | +$16K | ﹤0.01% | 1312 |
|
|
2022
Q1 | – | Sell |
-5
| Closed | -$5K | – | 2201 |
|
|
2021
Q4 | $5K | Sell |
5
-79
| -94% | -$79K | ﹤0.01% | 1614 |
|
|
2021
Q3 | $133K | Sell |
84
-4
| -5% | -$6.33K | 0.01% | 1046 |
|
|
2021
Q2 | $154K | Buy |
+88
| New | +$154K | 0.02% | 1083 |
|
|
2021
Q1 | – | Sell |
-57
| Closed | -$60K | – | 2142 |
|
|
2020
Q4 | $60K | Sell |
57
-51
| -47% | -$53.7K | 0.01% | 1189 |
|
|
2020
Q3 | $74K | Buy |
108
+103
| +2,060% | +$70.6K | 0.01% | 763 |
|
|
2020
Q2 | $6K | Buy |
+5
| New | +$6K | ﹤0.01% | 1192 |
|
|
2019
Q4 | $16K | Buy |
+12
| New | +$16K | ﹤0.01% | 1343 |
|
|
2018
Q4 | – | Sell |
-5
| Closed | -$27K | – | 2066 |
|
|
2018
Q3 | $27K | Buy |
+5
| New | +$27K | ﹤0.01% | 1371 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | -$7K | – | 2751 |
|
|
2017
Q4 | $7K | Sell |
1
-3
| -75% | -$21K | ﹤0.01% | 2274 |
|
|
2017
Q3 | $33K | Buy |
+4
| New | +$33K | ﹤0.01% | 2281 |
|